Prof O’Brien discusses the idea he proposed at the 2010 EHA congress: 'Patients should be 'forced' to enter clinical trials in order to receive the latest medication'. Prof O'Brien speaks about the current low patient uptake in clinical trials, explains the benefits of his proposal and considers the associated ethical problems. Prof O'Brien speculates why negative clinical trial results may not be published and suggests ways this can be remedied in future.